ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth

The NAV of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth is ₹38 as of Mon Sep 09 2024.

Net asset value, or NAV for short, is a mutual fund's cost per unit. Consider it the share price of a stock, but one that represents the total worth of all the investments made by the fund. This value affects how much you pay to invest or receive when redeeming units, and it changes every day based on changes in the market. Gaining insight into NAV enables you to evaluate a fund's performance and make wise investment choices.

Priyanka Khandelwal is the current fund manager of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth as on Tue Sep 10 2024. A fund manager's performance history, investment style and strategy, approach to risk management, tenure and experience, fees and charges, and alignment with investor goals all have an impact on the fund performance.

The Expense Ratio of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth is 194.00% as of Tue Sep 10 2024 which means if you earn ₹50,000 worth returns on an investment in this fund then 194.00% of those returns will be retained by the AMC.

The annual fees you pay the mutual fund firm to manage your investments in that fund are known as the Expense Ratio. The Expense Ratio is deducted from the returns that the fund generates and expressed as a percentage of Assets Under Management (AUM).

Because a smaller portion of the gains will be retained, a fund with a lower expense ratio is always preferable because it will result in larger returns for you.

The minimum Systematic Investment Plan (SIP) amount required for ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth is ₹100. A Systematic Investment Plan (SIP) is an investment approach in mutual funds where an investor selects a mutual fund scheme and invests a fixed amount at regular intervals. The SIP investment strategy involves investing a small amount consistently over time, as opposed to investing a large sum in a single instance. This method aims to potentially yield higher returns over the long term by leveraging the benefits of rupee cost averaging and compounding.

To initiate a lump sum investment in ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth, a minimum initial amount of ₹5,000 is necessary. This means that to participate in this investment option, investors must commit a starting sum of at least INR 5000. A lumpsum investment is a common approach to investing money in financial instruments such as mutual funds. This method involves investing a substantial sum of money in a financial instrument in a single transaction, as opposed to making multiple smaller payments over time.

In accordance with SEBI regulations, mutual funds are required to disclose the risk associated with investing, categorized into five levels: (a) Low: Low risk to principal, (b) Moderately Low: Moderately low risk to principal, (c) Moderate: Moderate risk to principal, (d) Moderately High: Moderately high risk to principal, (e) High: High risk to principal. The risk category of ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth is classified as Very High Risk.

The category of the ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Growth is Equity.